The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict UnitedHealth Group's revenues will increase 11.9% and EPS will decrease -1.6%.
The average estimate for revenue is $30.52 billion. On the bottom line, the average EPS estimate is $1.25.
Last quarter, UnitedHealth Group recorded revenue of $30.34 billion. GAAP reported sales were 11% higher than the prior-year quarter's $27.28 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, EPS came in at $1.16. GAAP EPS of $1.16 for Q1 were 11% lower than the prior-year quarter's $1.31 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 25.6%, 130 basis points worse than the prior-year quarter. Operating margin was 7.1%, 140 basis points worse than the prior-year quarter. Net margin was 3.9%, 120 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $122.86 billion. The average EPS estimate is $5.45.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 3,306 members out of 3,459 rating the stock outperform, and 153 members rating it underperform. Among 1,048 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 1,034 give UnitedHealth Group a green thumbs-up, and 14 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on UnitedHealth Group is buy, with an average price target of $65.92.
Is UnitedHealth Group the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add UnitedHealth Group to My Watchlist.